WallStreetZenWallStreetZen

NASDAQ: LFCR
Lifecore Biomedical Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Lifecore Biomedical revenue was $130.31M for the trailing 12 months ending Feb 23, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Feb 23, 2025 was $35.2M, up 8% from last quarter. For the last reported fiscal year 2024 ending May 26, 2024, LFCR annual revenue was $128.3M, with 24.2% growth year-over-year.

LFCR past revenue growth

How has LFCR's revenue growth performed historically?

Company
7.23%
Industry
10.38%
Market
20.68%
LFCR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LFCR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LFCR's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LFCR revenue history

Current Revenue
$130.3M
Current Earnings
-$49.4M
Current Profit Margin
-37.9%

Be the first to know when LFCR announces revenue.

LFCR Revenue History By Year

LFCR Yearly RevenueLFCR RevenueLFCR ChangeLFCR Revenue Growth
2024-05-26$128.26M$24.99M+24.20%
2023-05-28$103.27M-$8.00M-7.19%
2022-05-29$111.27M$10.40M+10.31%
2021-05-30$100.87M-$59.19M-36.98%
2020-05-31$160.07M-$397.49M-71.29%
2019-05-26$557.56M$33.33M+6.36%
2018-05-27$524.23M$54.45M+11.59%
2017-05-28$469.78M-$7.14M-1.50%
2016-05-29$476.92M-$62.34M-11.56%
2015-05-31$539.26M$62.44M+13.10%
2014-05-25$476.81M$35.11M+7.95%
2013-05-26$441.71M$124.16M+39.10%
2012-05-27$317.55M$40.82M+14.75%
2011-05-29$276.73M$38.51M+16.16%
2010-05-30$238.22M$2.29M+0.97%
2009-05-31$235.94M-$2.59M-1.09%
2008-05-25$238.53M$28.03M+13.32%
2007-05-27$210.50M-$21.46M-9.25%
2006-05-28$231.95M$26.72M+13.02%
2005-05-29$205.23M$13.14M+6.84%
2004-05-30$192.09MN/AN/A
2002-10-27$183.16M-$7.49M-3.93%
2001-10-28$190.65M-$6.58M-3.34%
2000-10-29$197.23M$175.78M+819.64%
1999-10-31$21.45M-$12.07M-36.01%
1998-10-31$33.52M$24.00M+252.21%
1997-10-31$9.52M$7.45M+360.38%
1996-10-31$2.07M-$1.39M-40.26%
1995-10-31$3.46M$1.76M+103.53%
1994-10-31$1.70MN/AN/A

1 of 2

Lifecore Biomedical Revenue FAQ

What was LFCR's revenue last quarter?

Lifecore Biomedical (NASDAQ: LFCR) reported Q1 2025 revenue of $35.15 million up 1.54% year over year. In the same quarter last year, Lifecore Biomedical's revenue was $35.70 million.

What was Lifecore Biomedical's revenue in 2024?

Lifecore Biomedical's annual revenue for the twelve months ending May 26, 2024 was $128.26 million, a 24.2% increase year over year.

How much does Lifecore Biomedical make in a day?

Based on Lifecore Biomedical annual revenue for the past five years, LFCR makes an average of $330,816.44 per day.

What was Lifecore Biomedical's annual revenue growth in the past year?

As of Q2 2025, Lifecore Biomedical's revenue has grown 7.23% year over year. This is 3.14 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.38%. Lifecore Biomedical's revenue in the past year totaled $130.31 million.

How much does Lifecore Biomedical make in a year?

Lifecore Biomedical's revenue by year for the past five years is:
  • Lifecore Biomedical's revenue for the twelve months ending May 26, 2024 was $128.26 million, a 24.2% increase year over year.
  • Lifecore Biomedical's annual revenue for May 28, 2023 was $103.27 million, a 7.19% decrease from 2022.
  • Lifecore Biomedical's annual revenue for 2022 was $111.27 million, a 10.31% increase from 2021.
  • Lifecore Biomedical's annual revenue for 2021 was $100.87 million, a 36.98% decrease from 2020.
  • Lifecore Biomedical's annual revenue for 2020 was $160.07 million, a 71.29% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.